Joosten, Stacey E. P.
Wellenstein, Marius
Koornstra, Rutger
van Rossum, Annelot
Sanders, Joyce http://orcid.org/0000-0002-0551-7813
van der Noort, Vincent
Ferrandez, Maria C.
Harkes, Rolf
Mandjes, Ingrid A. M.
Rosing, Hilde
Huitema, Alwin
Beijnen, Jos H.
Wesseling, Jelle http://orcid.org/0000-0002-8940-2676
van Diest, Paul J.
Horlings, Hugo M. http://orcid.org/0000-0003-4782-8828
Linn, Sabine C.
Zwart, Wilbert
Funding for this research was provided by:
Stichting A Sister’s Hope
KWF Kankerbestrijding
Article History
Received: 26 October 2020
Accepted: 21 September 2021
First Online: 20 October 2021
Competing interests
: The funder had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. Fulvestrant was provided by AstraZeneca. Gene expression was generated by Agendia Inc, partly under a service agreement, partly as a collaboration. Marius Wellenstein is Chief Operating Officer for WSK Medical B.V. The remaining authors declare no competing interests.